Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants | NEJM - nejm.org

Original Article from The New England Journal of Medicine — Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants

From the Department of International Health, Johns Hopkins University, Baltimore (L.L.H.), and AstraZeneca, Gaithersburg (Y.Y., D.B., A.G., P.R., T.T., M.E.A., A.L., M.P.G., T.V.) both in Maryland; t… [+1139 chars]

full article...